Sanjay R Chemburkar

USPTO Granted Patents = 27 (Patent Applications = 11)

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 76(Granted Patents)

Location History:

North Chicago, IL (US) (2017 - 2020)
Gurnee, IL (US) (1992 - 2023)

Company Filing History:

15 out of 4,179

Abbott Laboratories Corporation

Melinta Therapeutics, Inc.

patents

4. 1 out of 26

The Medicines Company

patents

where one patent can have more than one assignee

Years Active: 1992-2023

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542239 - Elagolix sodium compositions and processes (2023-01-03),

2. 10864249 - High purity oritavancin and method of producing same (2020-12-15),

3. 10689675 - Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid (2020-06-23),

4. 10465216 - Process for the preparation of (S)-2-amino-non-8-enoic acid (2019-11-05),

5. 10328118 - High purity oritavancin and method of producing same (2019-06-25),

6. 10316338 - Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid (2019-06-11),

7. 10113152 - Variant polypeptides capable of aminating aliphatic alpha keto acids (2018-10-30),

8. 10059969 - Process for the preparation of (S)-2-amino-non-8-enoic acid (2018-08-28),

9. 9649352 - High purity oritavancin and method of producing same (2017-05-16),

10. 9255092 - Polymorph of a pharmaceutical (2016-02-09),

11. 8796451 - Crystalline pharmaceutical (2014-08-05),

12. 8674112 - Polymorph of a pharmaceutical (2014-03-18),

13. 8288565 - Process for the synthesis of (2S,3AR,7AS)-octahydro-1H-indole carboxylic acid as an intermediate for trandolapril (2012-10-16),

14. 8193367 - Polymorph of a pharmaceutical (2012-06-05),

15. 8129521 - One pot synthesis of tetrazole derivatives of rapamycin (2012-03-06),

Title: The Innovation Journey of Inventor Sanjay R Chemburkar

Introduction: Sanjay R Chemburkar, a prolific inventor based in Gurnee, IL (US), has made significant contributions to the field of pharmaceuticals with a total of 27 patents to his name.

Latest Patents:

1. Elagolix sodium compositions and processes - Chemburkar's innovative work revolves around compositions of elagolix sodium, along with the processes and intermediates involved in their preparation.

2. High purity oritavancin and method of producing same - Chemburkar's patents also include drug substance preparations of oritavancin with high purity, pharmaceutical compositions containing such preparations, and drug products with these compositions.

Career Highlights: Throughout his career, Sanjay R Chemburkar has worked with esteemed companies such as Abbott Laboratories Corporation and AbbVie Inc., where he honed his skills and expertise in the pharmaceutical industry.

Collaborations: Chemburkar has collaborated with notable individuals in his field, including coworkers Ketan M Patel and Harry O Spiwek, fostering a culture of innovation and teamwork in his professional endeavors.

Conclusion: Sanjay R Chemburkar's relentless pursuit of innovation in pharmaceuticals has not only led to numerous patents but has also established him as a respected figure in the industry. His groundbreaking work continues to shape the landscape of pharmaceutical research and development, inspiring future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.